Conference themes
With 17+ hours of content, we will be tackling the key issues from the benchside to commercialization. By considering a range of therapeutic areas, the conference is designed exclusively for the Cannabinoid drug developer. Our speakers will discuss complex Cannabinoid pharmacology, formulations, clinical trials, patient education and commercial challenges.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Chris Bunka, Chairman of the Board and Chief Executive Officer, Lexaria Biosciences, Tamas Biro, Professor, Research Center for Molecular Medicine Departments of Immunology and Physiology, University of Debrecen, and others
Enquiries and Registration:
https://go.evvnt.com/267417-0?pid=4832
Ms. Kaltrina Kastrati
CategoriesPharmacology and Toxicology